Prostate cancer
A Study to Understand Changes in the small molecules present in the blood of Prostate Cancer Patients receiving radiotherapy (177Lu-PSMA)
Who can joinAdults
Age18+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial CentreNavi Mumbai, MaharashtraDirections ↗
Registry summary (technical)
Plasma Metabolomic Profiling following 177Lu -PSMA Therapy in Prostate Cancer - LuMaP Metabolomics
Sponsor: ACTREC Tata Memorial Centre (Intramural)
CTRI/2026/05/109917 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026